Bio-Techne opens GMP small molecule facility in Bristol, UK
The purpose-built site is fully operational and produces materials to support developers working on cell therapies globally.
Drug Development
Biohaven partners with Ono in $100m IgG degrader deal
FDA approves Pfizer’s Tukysa regimen for metastatic breast cancer
10x Genomics and Fred Hutch partner on cancer technologies
Rocket receives $150m credit facility to advance cardiovascular portfolio
Gilead Sciences signs five-year DevOps agreement with Cognizant
Pacira partners with Molteni for Exparel commercialisation
AstraZeneca opens new R&D centre in Cambridge, US
